Featured Articles

Stories about real people and real issues in our communities.

A New Way Of Managing BPH

02 March 2016 Written by  By Wei Zheng, MD
Published in March 2016 Articles

Benign enlargement of prostate (BPH) is one of the most common diseases that affects American men.

It has been estimated that 70% of all men have enlarged prostate by the age of 60. By age of 80, 90% of men are affected. In other words, every man will have BPH if he lives long enough!
Symptoms of BPH can be divided into two categories, obstructive and irritative voiding symptoms. Obstructive urinary symptoms consist of difficulty to initiate the urinary stream, intermittent and slow stream, and post void dribbling. Irritative voiding symptoms include sensation of not being able to empty, urinary frequency, urgency, urgent inconti­nence, burning upon urination and urge to get up at night to urinate.

There are many treatment options for BPH. When the symptoms are mild, watchful waiting is often recommended. When the symptoms become moderate or severe, they can be treated with medication, minimally invasive office procedures or surgeries.

There is a new procedure called UroLift System which was approved by the FDA within the last year. The UroLift System is a minimally invasive procedure to treat the BPH. It consists of a delivery device and tiny permanent implants which, once deployed in the prostatic urethra, can lift and hold the enlarged prostate tissue out of the way, alleviating compression on the urethra. No cutting, heating, or ablating tissue is involved in the UroLift procedure, making it a unique treatment that does not remove prostate tissue and does not negatively impact a man’s sexual function. The UroLift is done in an office setting under local anesthesia. It takes 20-30 minutes to perform. Patients can expect symptoms to improve within the first week, and continue improving up to three months. Patients may have some mild pelvic discomfort, small amount of blood in the urine and mild urgency and burning upon urination after the procedure. Patients can return to pre-procedural activity level within a week.

UroLift System has been evaluated and used extensively in Europe, Australia, and Canada within the last 5-6 years. It has been proven as an effective way of managing BPH. It is an excellent option for patients with BPH looking for an alternative to drug therapy or more invasive surgery.

Read 1815 times Last modified on Wednesday, 02 March 2016 23:03
Rate this item
(0 votes)

Subscribe to our virtual magazine

Email: